Fumoleau, Pierre <br/><br/>
Phase I dose-finding study of cabazitaxel administered weekly in patients with advanced solid tumours.  [electronic resource] 

 -  BMC cancer  Oct 2013 
 - 460 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1471-2407 
<br/><br/><label>Standard No.: </label>10.1186/1471-2407-13-460  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents, Phytogenic--pharmacology<br/>Combined Modality Therapy<br/>Female<br/>Humans<br/>Male<br/>Maximum Tolerated Dose<br/>Middle Aged<br/>Neoplasm Staging<br/>Neoplasms--diagnosis<br/>Taxoids--pharmacology<br/>Treatment Outcome